REFERENCES
- Abelev, G. Advanc. Cancer Res. 1971, 14, 295–358
- Gold, P. J. Exp. Med. 1965, 122, 467–481
- Hansen, H. J., Snyder, J. J., Miller, E., Vandevoorde, J. P., Miller, O. N., Hines, L. R. & Burns, J. J. Hum. Path. 1974, 5, 139–147
- Jakobsson, P. & Wahren, B. Importance of fetal antigens in serum of oesophagus cancer patients (Abstract in Swedish). Medicinsk Riksstämma, Stockholm, 1975
- Lokich, J. J., Skarin, A. T., Mayer, R. J. & Frei, E., III. Cancer 1977, 40, 2792–2796
- McIntire, K. R., Waldmann, T. A., Moertel, C. G. & Go, V. L. W. Cancer Res. 1975, 35, 991–996
- Moertel, C. G., Schutt, A. J. & Go, V. L. W. J. Amer. Med. Ass. 1978, 239, 1065–1066
- Ravry, M., McIntire, K. R., Moertel, C. G., Waldmann, T. A., Schutt, A. J. & Go, V. L. W. J. Natl. Cancer Inst. 1974, 52, 1019–1021
- Rieger, Å. & Wahren, B. Scand. J. Gastroent. 1975, 10, 869–874
- UICC. pp. 51–55 in Classification of Malignant Tumors, TNM System. International Union against Cancer, Geneva. 1974